Wollongong 3D bioprinters hit global stage

Prosthetists in India will have access to the latest advances in 3D bioprinting to correct ear deformities, thanks to ARC  Centre of Excellence for Electromaterials Science (ACES) researchers from the University of Wollongong (UOW). 

ACES researchers have dispatched two customised bioprinters designed and manufactured in Wollongong to Indian  medical device manufacturers as part of a strategic collaboration between UOW and Andhra Pradesh Medtech Zone  (AMTZ) in India.  

The 3D Genii printer is part of the package bound for AMTZ, which is designed to print implantable, flexible,  customised prosthetic ears that match the anatomy of patients suffering from microtia (a congenital deformity of the ear  that has a heightened rate of disease in India compared to Australia). 

The printer has been built specifically to deliver high precision silicon rubber prints in complex shapes, such as those  found in an ear. The patient’s ear is scanned using smart phone software, and the file is uploaded for printing.  

The 3D Genii will allow a prosthetist to complete their work faster and in a more streamlined manner, while providing  simple scanning technology that can be used remotely to ensure the system is more accessible across the broader  population. 

ACES Director, Distinguished Professor Gordon Wallace AO, said the delivery of printers to India is an exciting step in  accelerating new technologies, creating new industries and building local medtech infrastructure for both Australia and  India. 

“We’ve seen some impressive advances in the partnership between UOW and AMTZ in terms of identifying areas of  clinical need, developing the best strategies to meet that need, and bringing together the knowledge and expertise to  deliver the most effective solution in the least amount of time,” Professor Wallace said. 

“Both India and Australia have challenges in delivering health innovations to their rural areas. We hope these latest  developments will help in reaching out to those patients and healthcare professionals who can work remotely with us to  access 3D printing technologies.” 

AMTZ will also take receipt of the 3DREDI, a locally designed and manufactured 3D bioprinting research and  education system that equips users with the essential hardware and skills to embark on projects in the rapidly emerging  bioprinting industry.  

The platform has been developed with the input of world-leading clinicians and features an intuitive research  bioprinting platform that is capable of creating structures containing living cells. The system comes complete with  interactive printing and characterisation tutorials to allow educators and students to familiarise themselves with the  capabilities of multi-material bioprinting.  

The AMTZ team will utilise the 3DREDI system to advance their knowledge in bioprinting while focusing on the use  of 3D bioprinted structures for cardiac regeneration.  

UOW’s Global Brand Ambassador, Adam Gilchrist AM, said the 3D bioprinting collaboration has much to offer both  India and Australia in advancing research, training and manufacturing. 

“UOW already has many strong connections with India, and there’s so much more we could do together,” Mr Gilchrist said.

“It’s exciting to see UOW share its internationally renowned expertise in bioprinting to help India establish a state-of the-art, affordable and accessible industry that will have a real and significant impact in local communities in both India  and Australia.” 

UOW signed a strategic collaboration in Visakhapatnam (Vizag), India in 2019. Several research and training initiatives  have been established under the Memorandum of Understanding, including the development of the scan and printing  package to produce 3D printed ears, and innovative programs to support widespread deployment of the technology in  India and Australia. 

The project also received support from the Federal Government’s Australia-India Council (AIC), to build bilateral  partnerships to translate 3D bioprinting research in India, and is led in collaboration with RPA Ear, Nose and Throat  Surgeon Associate Professor Payal Mukherjee. 


TRICEP – UOW’s Translational Research Initiative for Cellular Engineering and Printing – is providing critical input  into both the research and training initiatives, and was responsible for the design and production of the 3D Genii and  3DREDI. TRICEP houses world-leading research infrastructure to develop innovative technologies in 3D bioprinting,  including printer manufacturing, biomaterials, and bioinks.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.